Docetaxel in der Behandlung anderer solider Tumoren
- 1 September 1997
- journal article
- Published by Springer Nature in Medizinische Klinik
- Vol. 92 (4) , 16-22
- https://doi.org/10.1007/bf03041971
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI Journal of the National Cancer Institute, 1996
- Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervixAnti-Cancer Drugs, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- 848 Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma (STS): A phase II trialEuropean Journal Of Cancer, 1995
- Docetaxel in advanced ovarian cancer: Preliminary results from three phase II trialsEuropean Journal Of Cancer, 1995
- Docetaxel delivers new management opportunities for gastrointestinal carcinomasAnti-Cancer Drugs, 1995
- Docetaxel: an Active New Drug for Treatment of Advanced Epithelial Ovarian CancerJNCI Journal of the National Cancer Institute, 1995
- Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991